Literature DB >> 2431280

4.5S RNA is encoded by hundreds of tandemly linked genes, has a short half-life, and is hydrogen bonded in vivo to poly(A)-terminated RNAs in the cytoplasm of cultured mouse cells.

L O Schoeniger, W R Jelinek.   

Abstract

4.5S RNA is a group of RNAs 90 to 94 nucleotides long (length polymorphism due to a varying number of UMP residues at the 3' end) that form hydrogen bonds with poly(A)-terminated RNAs isolated from mouse, hamster, or rat cells (W. R. Jelinek and L. Leinwand, Cell 15:205-214, 1978; F. Harada, N. Kato, and H.-O. Hoshino, Nucleic Acids Res. 7:909-917, 1979). We have cloned a gene that encodes the 4.5S RNA. It is repeated 850 (sigma = 54) times per haploid mouse genome and 690 (sigma = 59) times per haploid rat genome. Most, if not all, of the repeats in both species are arrayed in tandem. The repeat unit is 4,245 base pairs long in mouse DNA (the complete base sequence of one repeat unit is presented) and approximately 5,300 base pairs in rat DNA. This accounts for approximately 3 X 10(6) base pairs of genomic DNA in each species, or 0.1% of the genome. Cultured murine erythroleukemia cells contain 13,000 molecules per cell of the 4.5S RNA, which can be labeled to equilibrium in 90 min by [3H]uridine added to the culture medium. The 4.5S RNA, therefore, has a short half-life. The 4.5S RNA can be cross-linked in vivo by 4'-aminomethyl-4,5',8-trimethylpsoralen to murine erythroleukemia cell poly(A)-terminated cytoplasmic RNA contained in ribonucleoprotein particles.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431280      PMCID: PMC367676          DOI: 10.1128/mcb.6.5.1508-1519.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  The Chinese hamster Alu-equivalent sequence: a conserved highly repetitious, interspersed deoxyribonucleic acid sequence in mammals has a structure suggestive of a transposable element.

Authors:  S R Haynes; T P Toomey; L Leinwand; W R Jelinek
Journal:  Mol Cell Biol       Date:  1981-07       Impact factor: 4.272

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Light-induced cross-linking of DNA in the presence of a furocoumarin (psoralen). Studies with phage lambda, Escherichia coli, and mouse leukemia cells.

Authors:  R S Cole
Journal:  Biochim Biophys Acta       Date:  1970-09-17

4.  Psoralen monoadducts and interstrand cross-links in DNA.

Authors:  R S Cole
Journal:  Biochim Biophys Acta       Date:  1971-11-29

5.  Competition hybridization by "pre-saturation" of HeLa cell DNA.

Authors:  R Soeiro; J E Darnell
Journal:  J Mol Biol       Date:  1969-09-28       Impact factor: 5.469

6.  Gene linkage by RNA-DNA hybridization. II. Arrangement of the redundant gene sequences for 28 s and 18 s ribosomal RNA.

Authors:  D D Brown; C S Weber
Journal:  J Mol Biol       Date:  1968-06-28       Impact factor: 5.469

7.  Charon phages: safer derivatives of bacteriophage lambda for DNA cloning.

Authors:  F R Blattner; B G Williams; A E Blechl; K Denniston-Thompson; H E Faber; L Furlong; D J Grunwald; D O Kiefer; D D Moore; J W Schumm; E L Sheldon; O Smithies
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

8.  The ribonuclease activity of crystallized pancreatic deoxyribonuclease.

Authors:  S B Zimmerman; D Sandeen
Journal:  Anal Biochem       Date:  1966-02       Impact factor: 3.365

9.  5,6-Dichloro-1-Beta-D-ribofuranosylbenzimidazole inhibits initiation of nuclear heterogeneous RNA chains in HeLa cells.

Authors:  P B Sehgal; E Derman; G R Molloy; I Tamm; J E Darnell
Journal:  Science       Date:  1976-10-22       Impact factor: 47.728

10.  Synthesis and characterization of new psoralen derivatives with superior photoreactivity with DNA and RNA.

Authors:  S T Isaacs; C K Shen; J E Hearst; H Rapoport
Journal:  Biochemistry       Date:  1977-03-22       Impact factor: 3.162

View more
  11 in total

1.  Evolution of secondary structure in the family of 7SL-like RNAs.

Authors:  D Labuda; E Zietkiewicz
Journal:  J Mol Evol       Date:  1994-11       Impact factor: 2.395

2.  Recently transposed Alu repeats result from multiple source genes.

Authors:  A G Matera; U Hellmann; M F Hintz; C W Schmid
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

3.  The SRP9/14 subunit of the human signal recognition particle binds to a variety of Alu-like RNAs and with higher affinity than its mouse homolog.

Authors:  F Bovia; N Wolff; S Ryser; K Strub
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

4.  Compilation of small RNA sequences.

Authors:  R Reddy
Journal:  Nucleic Acids Res       Date:  1988       Impact factor: 16.971

5.  The emergence of new DNA repeats and the divergence of primates.

Authors:  P P Minghetti; A Dugaiczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

6.  A transpositionally and transcriptionally competent Alu subfamily.

Authors:  A G Matera; U Hellmann; C W Schmid
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

7.  Reconstruction and analysis of human Alu genes.

Authors:  J Jurka; A Milosavljevic
Journal:  J Mol Evol       Date:  1991-02       Impact factor: 2.395

8.  Newly arisen DNA repeats in primate phylogeny.

Authors:  S C Ryan; A Dugaiczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Gene duplication and neofunctionalization: POLR3G and POLR3GL.

Authors:  Marianne Renaud; Viviane Praz; Erwann Vieu; Laurence Florens; Michael P Washburn; Philippe l'Hôte; Nouria Hernandez
Journal:  Genome Res       Date:  2013-10-09       Impact factor: 9.043

10.  Complementarity of end regions increases the lifetime of small RNAs in mammalian cells.

Authors:  Anastasia P Koval; Irina K Gogolevskaya; Karina A Tatosyan; Dmitri A Kramerov
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.